摘要
目的探讨消化内镜黏膜下剥离术在消化道早癌治疗中的应用效果。方法选取医院2020年2月至2023年2月收治的消化道早癌患者110例,按随机数字表法分为对照组和观察组,各55例。对照组患者采用传统手术治疗,观察组患者采用消化内镜黏膜下剥离术治疗。结果观察组的治疗总有效率为98.18%,显著高于对照组的87.27%(P<0.05);观察组患者的术中出血量显著少于对照组(P<0.05),手术时间和住院时间均显著短于对照组(P<0.05);观察组患者的不良反应发生率为1.82%,显著低于对照组的14.55%(P<0.05)。结论消化内镜黏膜下剥离术用于治疗消化道早癌的临床疗效良好,可减少患者的术中出血量,缩短手术时间和住院时间,降低术后不良反应发生率。
Objective To investigate the application effect of endoscopic submucosal dissection in the treatment of early gastrointestinal cancer.Methods A total of 110 patients with early gastrointestinal cancer admitted to the hospital from February 2020 to February 2023 were selected and randomly divided into the control group and the observation group by the random number table method,with 55 cases in each group.The control group was treated with traditional surgery,while the observation group was treated with submucosal dissection under digestive endoscopy.Results The total effective rate in the observation group was 98.18%,which was significantly higher than 87.27%in the control group(P<0.05).The intraoperative blood loss in the observation group was significantly lower than that in the control group(P<0.05),and the surgical and hospital stay in the observation group were significantly shorter than those in the control group(P<0.05).The incidence of adverse reactions in the observation group was 1.82%,which was significantly lower than 14.55%in the control group(P<0.05).Conclusion Gastrointestinal endoscopic submucosal dissection has a good clinical efficacy in the treatment of early gastrointestinal cancer,which can reduce intraoperative bleeding,shorten surgical and hospitalization time,and reduce the incidence of postoperative adverse reactions.
作者
卢杰
陈时
LU Jie;CHEN Shi(Department of Gastroenterology,Hubei Aerospace Hospital,Xiaogan,Hubei,China 432000)
出处
《中国药业》
CAS
2024年第S02期123-125,共3页
China Pharmaceuticals
关键词
消化道早癌
消化内镜黏膜下剥离术
术中出血量
临床疗效
early gastrointestinal cancer
digestive endoscopic submucosal dissection
intraoperative bleeding loss
clinical efficacy